Genotype distribution and 5' UTR nucleotide changes in hepatitis C virus;Hepatit C virusu genotip daǧılımı ve 5' UTR nükleotid deǧişiklikleri

Balkan Medical Journal

Volumn 28, Issue 3, 2011, Pages 232-236

  Karsligil, Tekin ^a   Savaş, Eda ^a   Cemil Savas M ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

5' UTR nucleotid changes; Genotyping; HCV

Indexed keywords

VIRUS RNA;

5' UNTRANSLATED REGION; ARTICLE; CODON; GENE DELETION; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; NUCLEIC ACID BASE SUBSTITUTION; RNA ISOLATION; SEQUENCE HOMOLOGY; TREATMENT RESPONSE; VIRUS GENOME; VIRUS LOAD;

EID: 80053378813     PISSN: 21463123     EISSN: 21463131     Source Type: Journal    
DOI: 10.5174/tutfd.2010.04053.0     Document Type: Article

References (23)

1. Lavanchy D. The global burden of hepatitis C. Liver Int 2009;29:74-81.
2. Hüseyin Şener Barut, Özgür Günal. Dünyada ve Ülkemizde Hepatit C Epidemiyolojisi. Klimik Dergisi 2009;22:38-43.
3. Shuhart MC, Gretch DR. Hepatitis C and G Viruses, Patrick Murray edt. Manuel of Clinical Microbiology 2003;2:1480-94.
4. Davis GL. Hepatitis C virus genotypes and quasispecies. Am J Med 1999;107:21-6.
5. Pawlotsky JM. Virology of hepatitis B and C viruses and antiviral targets. J Hepatol 2006;44:10-3.
6. Glenn JS. Molecular virology of the hepatitis C virus: implication for novel therapies. Infect Dis Clin North Am 2006;20:81-98.
7. Bartenschlager R. The hepatitis C virus replicon system: from basic research to clinical application. J Hepatol 2005;43:210-6.
8. Ogata N, Alter HJ, Miller RH, Purcell RH. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci USA 1991;88:3392-6.
9. Domiati-Saad R, Scheuermann RH. Nucleic acid testing for viral burden and viral genotyping. Clin Chim Acta 2006;363:197-205.
10. Smith DB, Simmonds P. Review: Molecular epidemiology of hepatitis C virus. J Gastroenterol Hepatol 1997;12:522-7.
11. Altindis M, Yilmaz S, Dikengil T, Acemoglu H, Hosoglu S. Seroprevalence and genotyping of hepatitis B, hepatitis C and HIV among healthy population and Turkish soldiers in Northern Cyprus. World J Gastroenterol 2006;12:6792-6.
12. Selcuk H, Kanbay M, Korkmaz M, Gur G, Akcay A, Arslan H, et al. Distribution of HCV Genotypes in Patients with End-Stage Renal Disease According to Type of Dialysis Treatment. Dig Dis Sci 2006;51:1420-5.
13. Abacioglu YH, Davidson F, Tuncer S, Yap PL, Ustacelebi S, Yulug N, et al. The distribution of hepatitis C virus genotypes in Turkish patients. J Viral Hepat 1995;2:297-301.
14. Bozdayi G, Rota S, Verdi H, Derici U, Sindel S, Bali M, et al. The presence of hepatitis C virus (HCV) infection in hemodialysis patients and determination of HCV genotype distribution. Mikrobiyol Bul 2002;36:291-300.
15. Yildiz E, Oztan A, Sar F, Pinarbasi E, Cetin-Atalay R, Akkiz H, et al. Molecular characterization of a full genome Turkish hepatitis C virus 1b isolate (HCV-TR1): a predominant viral form in Turkey. Virus Genes 2002;25:169-77.
16. Hofmann WP, Zeuzem S, Sarrazin C. Hepatitis C virus-related resistance mechanisms to interferon alpha-based antiviral therapy. J Clin Virol 2005;32:86-91.
17. Jubin R. Hepatitis C IRES: translating translation into a therapeutic target. Curr Opin Mol Ther 2001;3:278-87.
18. Kanda T, Steele R, Ray R, Ray RB. Small interfering RNA targeted to hepatitis C virus 5' nontranslated region exerts potent antiviral effect. J Virol 2007;81:669-76.
19. Laporte J, Malet I, Andrieu T, Thibault V, Toulme JJ, Wychowski C, et al. Comparative analysis of translation efficiencies of hepatitis C virus 5' untranslated regions among intraindividual quasispecies present in chronic infection: opposite behaviors depending on cell type. J Virol 2000;74:10827-33.
20. Zekri AR, El-Din HM, Bahnassy AA, Khaled MM, Omar A, Fouad I, et al. Genetic distance and heterogenecity between quasispecies is a critical predictor to IFN response in Egyptian patients with HCV genotype-4. Virol J 2007;4:1-12.
21. Suzuki K, Shinzawa H, Kuboki M, Ishibashi M, Yoshii E, Saito T, et al. Secondary structure of the hepatitis C virus 5' untranslated region and efficacy of interferon therapy for chronic hepatitis C. Liver 1998;18:331-6.
22. Thelu MA, Drouet E, Hilleret MN, Zarski JP. Lack of clinical significance of variability in the internal ribosome entry site of hepatitis C virus. J Med Virol 2004;72:396-405.
23. Soler M, Pellerin M, Malnou CE, Dhumeaux D, Kean KM, Pawlotsky JM. Quasispecies heterogeneity and constraints on the evolution of the 5' noncoding region of hepatitis C virus (HCV): relationship with HCV resistance to interferon-alpha therapy. Virology 2002;298:160-73.